| Type | Public |
|---|---|
| Traded as | BSE: 524715 NSE: IPCALAB |
| Industry | Pharmaceutical |
| Founded | 19th October, 1949 (Mumbai) |
| Founder(s) | K.B. Mehla,Dr. N.S. Tibrawala |
| Headquarters | Mumbai, India[1] |
| Area served | worldwide |
| Key people | Prem Chand Godha, MD,[2] Mr. AK Jain, JMD[3] |
| Products | Pharmaceuticals, drugs |
| Revenue | 1,558.95 crore (US$296.2 million) [4] |
| Employees | 8,001 (2011) |
| Subsidiaries | CCPL Software,[5] Ipca Traditional Remedies [6] |
| Website | www.ipcalabs.com |
Ipca Laboratories (BSE: 524494, NSE: IPCALAB) is an international pharmaceutical company based in Mumbai, India. It is also one of the largest suppliers of these APIs and their intermediates world over.[7] It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.[8] The various kinds of drug intermediates that the company manufactures include Theo bromine, Acetylthiophene, and P- Bromo Toluene and promotes over 36 countries of Asia, Africa, CIS, and South America, including Cambodia, Kazakhstan, Kenya, Mauritius, Myanmar, Nigeria, Oman, Russia, Sri Lanka, Sudan, Tanzania, Ukraine, Vietnam and Yemen. The main activities of company are to produce and market pharmaceuticals and drugs. The various products of the company include formulations, drug intermediates, and active pharmaceutical ingredients (API).
In 2004, Forbes selected Ipca, for the second consecutive year as one among the first 200 'Best under a Billion Company' in Asia.[9]
It also got certification from US Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA).
It was founded by group of businessmen and medical professionals in 1949.[10] In 1975, the management of the company was taken over by Amitabh Bachchan, Ajitabh Bachchan, Jaya Bachchan, M.R. Chandurkar, P.C. Godha.[9]